U.S. legislative proposals requesting the National Academies study feasibility and benefits of delinking pharmaceutical innovation from drug prices KEI Briefing Note 2026:3 May 4, 2026 Zazie Huml KEI-BN-2026-3 Several members of Congress have asked the U.S. National Academies to study… Continue Reading →
Cost of initial risdiplam trials The cost of trials used to support the initial FDA approval of risdiplam (Evrysdi) KEI Research Note 2025:2 James Packard Love April 23, 2025
rn-2025-1 Timeline: Development of Risdiplam KEI Research Note 2025:1 April 7, 2025 Arianna Schouten
The USPTO has a request for comment on the need for a statutory experimental use exception for patents. (89 FR 53963). The USPTO uploads the comments to Regulations.Gov, docket PTO-C-2024-0023. KEI filed comments on September 10, 2024: KEI-Experimental-use-exception-10Sept2024 September 10,… Continue Reading →
On Monday afternoon, 9 September 2024, Knowledge Ecology International (KEI) delivered this statement on the legal architecture of the proposal for the WHO Pandemic Agreement. KEI has an open mind regarding the appropriate nature of the instrument or instruments for… Continue Reading →
In advance of the September 2024 WHO pandemic negotiations (INB 11), Knowledge Ecology International (KEI), Innovarte, and Medicines Law & Policy (ML&P) will convene a virtual panel entitled, “Reflections on the IP & Technology Transfer provisions of the WHO Pandemic… Continue Reading →
On Friday, 26 April 2024, the World Health Organization (WHO) circulated the 72-page annotated on-screen Bureau text of the Working Group on Amendments to the International Health Regulations (2005) (WGIHR)to Member States. Knowledge Ecology International (KEI) has obtained a copy… Continue Reading →
On Wednesday, 17 April 2024 at 15:25 CEST, the WHO secretariat circulated an advance, unedited English version of the proposed draft WHO Pandemic Agreement; the WHO secretariat also circulated the accompanying draft resolution, WHA77.1 WHO Pandemic Agreement. For KEI’s analysis… Continue Reading →
INB 9 Written statement by Knowledge Ecology International 28 March 2024 Transparency The negotiations on a WHO pandemic agreement should be more transparent. The negotiating texts with attributed country positions should be public and the meetings should be webcast. These… Continue Reading →
On Monday, 18 March 2024, Knowledge Ecology International (KEI) delivered the following oral statement (in person) at the 9th meeting of the World Health Organization’s (WHO) Intergovernmental Negotiating Body (INB). With respect to Article 11.2, the current references to “to… Continue Reading →